Also known as: Cambridge Bio-Augmentation Systems, BIOS
Neural interfaces to understand and use nerve data in medicine.
Company is active
Event Year: 2016
Company is active
Event Year: 2016
BIOS Health, formerly known as Cambridge Bio-Augmentation Systems (CBAS), initially concentrated on neural interfaces for prosthetics as its primary market entry point. The company's current focus involves leveraging neural interfaces to interpret and utilize nerve data within the broader medical field, expanding beyond its initial prosthetic-specific applications.
BIOS Health, formerly known as Cambridge Bio-Augmentation Systems (CBAS), initially concentrated on neural interfaces for prosthetics as its primary market entry point. The company's current focus involves leveraging neural interfaces to interpret and utilize nerve data within the broader medical field, expanding beyond its initial prosthetic-specific applications.
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2017
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2017
Healthcare
Healthcare
Healthcare
Healthcare
Team size: 45
Hiring: No
Team size: 45
Hiring: No
